E.G. Spokes

2.8k total citations
23 papers, 1.9k citations indexed

About

E.G. Spokes is a scholar working on Cellular and Molecular Neuroscience, Neurology and Psychiatry and Mental health. According to data from OpenAlex, E.G. Spokes has authored 23 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cellular and Molecular Neuroscience, 9 papers in Neurology and 5 papers in Psychiatry and Mental health. Recurrent topics in E.G. Spokes's work include Neuroscience and Neuropharmacology Research (7 papers), Neurological disorders and treatments (7 papers) and Genetic Neurodegenerative Diseases (6 papers). E.G. Spokes is often cited by papers focused on Neuroscience and Neuropharmacology Research (7 papers), Neurological disorders and treatments (7 papers) and Genetic Neurodegenerative Diseases (6 papers). E.G. Spokes collaborates with scholars based in United Kingdom and United States. E.G. Spokes's co-authors include Edward D. Bird, Richard Mindham, Thomas A. Hughes, Leslie L. Iversen, Sharmistha Bhattacherjee, Sunday Abraham Musa, Jean S. Gale, Terry Reisine, Henry I. Yamamura and Michael Shepherd and has published in prestigious journals such as Science, The Lancet and Brain.

In The Last Decade

E.G. Spokes

23 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E.G. Spokes United Kingdom 17 1.1k 896 554 363 259 23 1.9k
O Hornykiewicz Austria 22 1.5k 1.4× 1.2k 1.4× 628 1.1× 179 0.5× 283 1.1× 46 2.6k
W Danielczyk Austria 24 539 0.5× 645 0.7× 382 0.7× 488 1.3× 198 0.8× 77 1.8k
Urpo K. Rinne Finland 24 743 0.7× 1.5k 1.6× 256 0.5× 356 1.0× 290 1.1× 44 2.3k
William J. McEntee United States 23 762 0.7× 451 0.5× 321 0.6× 182 0.5× 638 2.5× 35 1.8k
L. Rouquier France 15 872 0.8× 545 0.6× 433 0.8× 263 0.7× 332 1.3× 18 1.6k
Paolo Del Dotto Italy 26 783 0.7× 1.5k 1.7× 254 0.5× 221 0.6× 267 1.0× 46 2.1k
Daniele Bravi Italy 22 485 0.5× 649 0.7× 312 0.6× 387 1.1× 144 0.6× 38 1.5k
Richard E. Wilcox United States 23 1.1k 1.0× 336 0.4× 600 1.1× 175 0.5× 285 1.1× 82 1.9k
F. Javoy France 23 1.6k 1.5× 551 0.6× 728 1.3× 167 0.5× 269 1.0× 38 2.3k
Zehava Gottesfeld United States 24 1.1k 1.0× 235 0.3× 542 1.0× 130 0.4× 259 1.0× 70 1.9k

Countries citing papers authored by E.G. Spokes

Since Specialization
Citations

This map shows the geographic impact of E.G. Spokes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.G. Spokes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.G. Spokes more than expected).

Fields of papers citing papers by E.G. Spokes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.G. Spokes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.G. Spokes. The network helps show where E.G. Spokes may publish in the future.

Co-authorship network of co-authors of E.G. Spokes

This figure shows the co-authorship network connecting the top 25 collaborators of E.G. Spokes. A scholar is included among the top collaborators of E.G. Spokes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E.G. Spokes. E.G. Spokes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hughes, Thomas A., et al.. (2004). Mortality in Parkinson's disease and its association with dementia and depression. Acta Neurologica Scandinavica. 110(2). 118–123. 153 indexed citations
2.
Hughes, Thomas A., et al.. (2000). A 10-year study of the incidence of and factors predicting dementia in Parkinson’s disease. Neurology. 54(8). 1596–1603. 288 indexed citations
3.
Spokes, E.G.. (1993). BOOK REVIEWS: Tardive Dyskinesia: A Task Force Report of The American Psychiatric Association.. Journal of Neurology Neurosurgery & Psychiatry. 56(5). 579–580. 1 indexed citations
4.
Mindham, R. H. S., et al.. (1992). A controlled, longitudinal study of dementia in Parkinson's disease.. Journal of Neurology Neurosurgery & Psychiatry. 55(7). 566–571. 91 indexed citations
5.
Mindham, R. H. S., et al.. (1991). Cognitive impairment and dementia in Parkinson's disease: a controlled study. Psychological Medicine. 21(4). 911–921. 16 indexed citations
6.
Crow, Timothy J., et al.. (1982). Familial cerebral amyloidosis and spongiform encephalopathy.. Journal of Neurology Neurosurgery & Psychiatry. 45(1). 37–45. 47 indexed citations
7.
Spokes, E.G.. (1981). The neurochemistry of Huntington's chorea. Trends in Neurosciences. 4. 115–118. 38 indexed citations
8.
Smith, John A., et al.. (1981). HUMAN POST‐MORTEM PINEAL ENZYME ACTIVITY. Clinical Endocrinology. 14(1). 75–81. 16 indexed citations
9.
Spokes, E.G.. (1980). NEUROCHEMICAL ALTERATIONS IN HUNTINGTON'S CHOREA. Brain. 103(1). 179–210. 226 indexed citations
10.
Reisine, T, Martin N. Rossor, E.G. Spokes, L L Iversen, & Yamamura Hi. (1980). Opiate and neuroleptic receptor alterations in human schizophrenic brain tissue.. PubMed. 21. 443–50. 27 indexed citations
11.
Spokes, E.G.. (1980). Brain temperature after death. Journal of Neuroscience Methods. 2(1). 105–106. 1 indexed citations
12.
Emson, P.C., Jan Fahrenkrug, & E.G. Spokes. (1979). Vasoactive intestinal polypeptide (VIP): distribution in normal human brain and in Huntington's disease. Brain Research. 173(1). 174–178. 65 indexed citations
13.
Spokes, E.G., et al.. (1979). Antipsychotic Drug Action in Schizophrenic Patients: Effect on Cortical Dopamine Metabolism After Long-Term Treatment. Science. 205(4413). 1405–1407. 85 indexed citations
14.
Bird, Edward D., E.G. Spokes, & Leslie L. Iversen. (1979). INCREASED DOPAMINE CONCENTRATION IN LIMBIC AREAS OF BRAIN FROM PATIENTS DYING WITH SCHIZOPHRENIA. Brain. 102(2). 347–360. 162 indexed citations
15.
16.
Gale, Jean S., Edward D. Bird, E.G. Spokes, L L Iversen, & Thomas M. Jessell. (1978). Human brain substance P: distribution in controls and Huntington's chorea. Journal of Neurochemistry. 30(3). 633–634. 114 indexed citations
17.
Reisine, T, et al.. (1978). Characterization of brain dopaminergic receptors in Huntington's disease.. PubMed. 2(2). 79–84. 15 indexed citations
18.
19.
Reisine, Terry, Jeremy Z. Fields, Henry I. Yamamura, et al.. (1977). Neurotransmitter receptor alterations in Parkinson's disease. Life Sciences. 21(3). 335–343. 205 indexed citations
20.
Bird, E. D., Jean S. Gale, & E.G. Spokes. (1977). HUNTINGTON'S CHOREA: POST MORTEM ACTIVITY OF ENZYMES INVOLVED IN CEREBRAL GLUCOSE METABOLISM. Journal of Neurochemistry. 29(3). 539–545. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by O Hornykiewicz Breakdown of academic impact, for papers by W Danielczyk Breakdown of academic impact, for papers by Urpo K. Rinne Breakdown of academic impact, for papers by William J. McEntee Breakdown of academic impact, for papers by L. Rouquier Breakdown of academic impact, for papers by Paolo Del Dotto Breakdown of academic impact, for papers by Daniele Bravi Breakdown of academic impact, for papers by Richard E. Wilcox Breakdown of academic impact, for papers by F. Javoy Breakdown of academic impact, for papers by Zehava Gottesfeld
Rankless by CCL
2026